Saturday, October 3, 2026

USD/EUR Rises By 1% In The Last 10 Sessions

USD/EUR Rises By 1% In The Last 10 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 1.26% for the last 10 sessions. At 15:09 EST on Wednesday, 5 July, USD/EUR (USDEUR) is $0.92.

USD/EUR's yearly highs and lows, it's 2.185% up from its 52-week low and 12.126% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a positive 0.21%, a negative 0.08%, and a positive 0.33%, respectively.

USD/EUR's highest amplitude of average volatility was 0.21% (last week), 0.32% (last month), and 0.33% (last quarter), respectively.

News about

  • Usd/jpy technical analysis: selling operations May occur at any time - 03 July 2023. According to DailyForex on Monday, 3 July, "On the economic side, the USD/JPY currency pair is trading affected by the results of the latest economic data this morning. ", "The price of the USD/JPY currency pair jumped to the 145.06 resistance level above It is more than seven months old, and it is settling around 144.70 at the time of writing. "
  • Usd/jpy defends 100-hour sma, trades with a mild positive bias below mid-144.00s. According to FXStreet on Monday, 3 July, "The USD/JPY pair struggles to gain any meaningful traction on Monday and oscillates in a narrow trading band, just above the 100-hour Simple Moving Average (SMA) through the Asian session. ", "In the meantime, traders might refrain from placing aggressive directional bets around the USD/JPY pair."
  • Usd/jpy signal: potential buying opportunity today - 03 July 2023. According to DailyForex on Monday, 3 July, "This discrepancy favors continued upward momentum in the USD/JPY pair over the long term. ", "The bullish patterns and interest rate differentials suggest a favorable long-term outlook for the USD/JPY pair. "
  • Usd/jpy trades with a mild negative bias around mid-144.00s, downside seems cushioned. According to FXStreet on Tuesday, 4 July, "The USD/JPY pair struggles to capitalize on the previous day's positive move back closer to the 145.00 psychological mark and edges lower during the Asian session on Tuesday. ", "That said, expectations that the BoJ will stick to its ultra-ease monetary policy stance keep a lid on any meaningful gains for the JPY and lend some support to the USD/JPY pair. "
  • Usd/jpy hovers around mid-144.00s as yields flag recession, Japan intervention looms. According to FXStreet on Tuesday, 4 July, "Also challenging the USD/JPY buyers are the fears of recession signaled via the US Treasury bond yields inversion.", "Moving on, the US holiday will restrict immediate USD/JPY moves but the fears of market intervention can check the bullish bias despite hawkish Fed bets, favoring a 0.25% rate hike in July."

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com